Xcout Intel
Boehringer Ingelheim competitors & alternatives
The 12 closest competitors and alternatives to Boehringer Ingelheim among pharmaceuticals companies — ranked by similarity to what Boehringer Ingelheim actually does, not by market-cap band.
Subscribe to see Boehringer Ingelheim’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Boehringer Ingelheim
Boehringer Ingelheim is a privately held pharmaceutical company that develops and manufactures prescription medicines for human healthcare, including therapies in areas such as cardiovascular, respiratory, metabolic, immunology and oncology. It also provides animal-health medicines and vaccines through its Boehringer Ingelheim Animal Health business, serving healthcare professionals, patients and veterinary customers worldwide.
Recent Boehringer Ingelheim news
Top 12 Boehringer Ingelheim competitors
Ranked by semantic similarity — how close each company is to Boehringer Ingelheim by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar pharmaceuticals company
Orion Oyj is a pharmaceutical and healthcare company that develops, manufactures, and markets medicines, self-care products, active pharmaceutical ingredients, and animal health products. The company serves patients, healthcare professionals, and the veterinary sector globally with treatments focused on therapy areas such as oncology, respiratory diseases, and neurology.
Similar pharmaceuticals company
Merck & Co., Inc. is a global healthcare leader with operations spanning two core divisions: Pharmaceuticals and Animal Health. The Pharmaceutical segment is dedicated to human health, offering a broad spectrum of medicinal products. These cover crucial therapeutic areas such as oncology, acute hospital care, immunology, neuroscience, virology, cardiovascular conditions, and diabetes. This division also develops vital preventive vaccines for pediatric, adolescent, and adult populations. Meanwhile, the Animal Health segment focuses on the research, development, manufacturing, and marketing of veterinary medications, vaccines, and comprehensive health management solutions for animals. This division further provides innovative digital products designed for animal identification, traceability, and continuous monitoring. Merck's extensive clientele encompasses drug wholesalers, pharmacies, hospitals, and government agencies. It also serves managed healthcare organizations, including health maintenance organizations (HMOs) and pharmacy benefit managers, as well as various other institutional clients. Additionally, the company supplies products to individual physicians and their distributors, veterinarians, and livestock producers. The organization actively engages in strategic collaborations with companies such as AstraZeneca PLC, Bayer AG, Eisai Co., Ltd., Ridgeback Biotherapeutics, and Gilead Sciences, Inc. These partnerships are specifically aimed at the joint development and commercialization of prolonged-acting therapies for HIV. Established in 1891, Merck & Co., Inc. maintains its corporate headquarters in Kenilworth, New Jersey.
Similar pharmaceuticals company
DEVA Holding is a pharmaceutical company that develops and manufactures human and veterinary medicines, active pharmaceutical ingredients, and healthcare solutions.
Similar pharmaceuticals company
Krka is a multinational generic pharmaceutical company that develops, produces, and markets prescription pharmaceuticals, non-prescription products, and animal health products.
Similar pharmaceuticals company
União Química Farmacêutica Nacional S.A. is a Brazilian pharmaceutical manufacturer that develops and produces medicines for human healthcare, including prescription, over-the-counter, and hospital products. It also operates in animal health and serves pharmacies, hospitals, healthcare providers, and veterinary markets in Brazil and other countries.
Similar pharmaceuticals company
Orion Pharma is a globally operating Nordic pharmaceutical company headquartered in Espoo, Finland. The company focuses on building well-being and sells its products in over a hundred countries worldwide, including through its Animal Health offices in Turku.
Similar pharmaceuticals company
Daiichi Sankyo Company, Limited is a global pharmaceutical enterprise actively involved in the research, development, manufacturing, importation, marketing, and distribution of a diverse array of medicinal products worldwide. Its extensive product lineup addresses numerous therapeutic areas. In oncology, key offerings include trastuzumab deruxtecan, an anti-HER2 antibody drug conjugate, alongside treatments like Gefitinib for malignant tumors, Bicalutamide for prostate cancer, and Tamoxifen, an anti-breast cancer agent. For pain management, the company provides mirogabalin and loxoprofen (an anti-inflammatory analgesic). Diabetes treatments feature teneligliptin/canagliflozin and teneligliptin, with colesevelam serving dual purposes for hypercholesterolemia and type 2 diabetes. Other notable prescription drugs include lacosamide (an anti-epileptic), prasugrel (an antiplatelet), denosumab (for osteoporosis and bone disorders), edoxaban (an anticoagulant), esomeprazole (for ulcer treatment), memantine (for Alzheimer's disease), and laninamivir (for influenza). The company also supplies olmesartan (an antihypertensive), levofloxacin (an antibacterial), pravastatin (for hypercholesterolemia), Silodosin (for dysuria), and ferric carboxymaltose/iron sucrose injections for anemia. Beyond prescription medications, Daiichi Sankyo markets popular consumer health brands such as Lulu (a combination cold remedy), Loxonin S (an antipyretic/anti-inflammatory painkiller), Transino (for melasma and skin improvement), Minon (skincare), and the oral care lines Breath Labo and Clean Dental. The company further contributes to public health with various vaccines, including adsorbed cell culture-derived influenza, influenza HA, measles-rubella combined, and mumps vaccines. Its operations also extend beyond human pharmaceuticals to include veterinary drugs, cosmetics, medical equipment, food products, drinking water, and the production of active pharmaceutical ingredients (APIs) and intermediates. Daiichi Sankyo is collaborating with Guardant Health on the development of Guardant360 CDx, a companion diagnostic for Enhertu, specifically for advanced metastatic non-small cell lung cancer. Founded in 1899, the company is headquartered in Tokyo, Japan.
Similar pharmaceuticals company
Antibiotice SA manufactures and distributes human pharmaceutical products, including prescription and over-the-counter medicines, as well as active pharmaceutical ingredients and veterinary products. The company serves patients, healthcare professionals, and veterinary markets by providing accessible healthcare treatments.
Similar pharmaceuticals company
Orion Corporation, founded in 1917 and headquartered at Espoo, Finland, is a globally operating Finnish company which develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients for global markets. All of the company's manufacturing sites and the majority of its R&D units are in Finland.
Similar pharmaceuticals company
Merck KGaA is a German science and technology company with operations divided into three core segments: Life Science, Healthcare, and Electronics. The Life Science division supplies essential tools, chemicals, and equipment to academic research institutions, biotechnology firms, pharmaceutical manufacturers, and various industrial sectors. It also offers specialized process development expertise, such as continuous bioprocessing for drug manufacturers, provides a range of testing kits, reagents, and services, and develops solutions for analyzing environmental samples like air, water, and soil. Furthermore, this segment aids in assessing nutritional value and identifying quality control issues. In its Healthcare segment, the company is involved in the entire lifecycle of prescription drugs and biopharmaceuticals, from initial discovery and development through manufacturing and marketing. Its therapeutic focus areas include oncology, neurology and immunology, fertility, endocrinology, cardiovascular diseases, diabetes, thyroid disorders, and multiple sclerosis. This segment also produces general medicines, injection devices, and software for disease monitoring. The Electronics division delivers critical materials for the semiconductor and display industries. It also specializes in surface design, providing delivery systems and services, along with a variety of surface solutions for applications such as cosmetics, effect pigments, and other functional materials. Merck KGaA is also actively engaged in strategic partnerships. These include in-licensing agreements with Debiopharm International SA for developing treatments for head and neck cancer, with Jiangsu Hengrui Pharmaceuticals Co. Ltd. for metastatic colorectal cancer drug candidates, and with Abbisko Therapeutics Co. Ltd. for therapies targeting tenosynovial giant cell tumors. Additionally, the company is involved in collaborations focused on discovering and developing targeted protein degraders against critical oncogenic proteins. Founded in 1668 and headquartered in Darmstadt, Germany, Merck KGaA operates as a subsidiary of E. Merck KG.
Similar pharmaceuticals company
Cronus Pharma is an integrated animal health pharmaceutical company headquartered in East Brunswick, New Jersey. The privately held company is dedicated to providing quality and cost-effective pharmaceutical products.
Similar pharmaceuticals company
Chanelle Pharma is a global pharmaceutical manufacturing company headquartered on an 18-acre campus in Loughrea, County Galway, Ireland. Backed by over 35 years of research and development, the company holds thousands of registered product licenses for human and animal health worldwide.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Boehringer Ingelheim and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Boehringer Ingelheimand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →